1 |
Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 2006;101:76-82
DOI
PUBMED
ScienceOn
|
2 |
Pendino GM, Mariano A, Surace P, Caserta CA, Fiorillo MT, Amante A, Bruno S, Mangano C, Polito I, Amato F, Cotichini R, Stroffolini T, Mele A; ACE Collaborating Group. Prevalence and etiology of altered liver tests: a popu-lation-based survey in a Mediterranean town. Hepatology 2005; 41: 1151-1159
DOI
ScienceOn
|
3 |
Kim IK, Kim J, Kang JH, Song J. Serum leptin as a predictor of fatty liver in 7-year-old Korean children. Ann Nutr Metab 2008; 53: 109-116
DOI
ScienceOn
|
4 |
Gupte P, Amarapurkar D, Agal S, Baijal R, Kulshrestha P, Pramanik S, Patel N, Madan A, Amarapurkar A, Hafeezunnisa. Nonalcoholic steatohe-patitis in type 2 diabetes mellitus. J Gastroenterol Hepatol 2004; 19: 854-858
DOI
ScienceOn
|
5 |
Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of nonalcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006; 22: 437-443
DOI
PUBMED
ScienceOn
|
6 |
World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment: IOTF, Health Communications Australia Pty Ltd., Brisbane; 2000
|
7 |
Song HR, Yun KE, Park HS. Relation between alanine aminotransferase concentrations and visceral fat accumulation among nondiabetic overweight Korean women. Am J Clin Nutr 2008; 88: 16-21
PUBMED
|
8 |
Kim J. The presence of Diabetes Mellitus and Anemia in Korean Adults-based on data from 2005 Korean National Health and Nutrition Examination Survey (KNHANES III). Korean J Nutr 2008; 41: 502-509
과학기술학회마을
|
9 |
Alberti KG, Zimmet P, Shaw J. The metabolic syndrome--a new worldwide definition. Lancet 2005; 366: 1059-1062
DOI
ScienceOn
|
10 |
Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, Mabuchi H, Teramoto T, Sasaki J, Nakaya N, Itakura H, Ishikawa Y, Ouchi Y, Horibe H, Shirahashi N, Kita T. Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb 2006; 13: 202-208
|
11 |
Schindhelm RK, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ, Diamant M. Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study. Diabet Med 2007; 24: 430-435
DOI
ScienceOn
|
12 |
Kwon JH, Bae SH. Current status and clinical course of hepatitis C virus in Korea. Korean J Gastroenterol 2008; 51: 360-367
PUBMED
|
13 |
Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-117
PUBMED
|
14 |
Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960-967
DOI
ScienceOn
|
15 |
Assy N, Kaita K, Mymin D, Levy C, Rosser B, Minuk G. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000; 45: 1929-1934
DOI
ScienceOn
|
16 |
Oh SY, Cho YK, Kang MS, Yoo TW, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, Son BH, Shin JH. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 2006; 55: 1604-1609
DOI
PUBMED
ScienceOn
|
17 |
Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 2005; 28: 2913-2918
DOI
ScienceOn
|
18 |
van Helden J, Denoyel G, Karwowska S, Reamer R, Schmalz J, Wright T, Preisel-Simmons B. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System. Clin Lab 2004; 50: 63-73
PUBMED
|
19 |
Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122: 1649-1657
DOI
ScienceOn
|
20 |
Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, Yueh SK. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol 2006; 40: 745-752
DOI
PUBMED
ScienceOn
|
21 |
Saito T, Misawa K, Kawata S. 1. Fatty liver and non-alcoholic steatohepatitis. Intern Med 2007; 46: 101-103
DOI
|
22 |
Saito T, Nishise Y, Makino N, Haga H, Ishii R, Okumoto K, Ito JI, Watanabe H, Saito K, Takeda H, Togashi H, Kubota I, Daimon M, Kato T, Kawata S. Impact of metabolic syndrome on elevated serum alanine aminotransferase levels in the Japanese population. Metabolism 2009; 58: 1067-1075
DOI
ScienceOn
|
23 |
Olynyk JK, Knuiman MW, Divitini ML, Davis TM, Beilby J, Hung J. Serum alanine aminotransferase, metabolic syndrome, and cardiovascular disease in an Australian population. Am J Gastroenterol 2009; 104: 1715-1722
DOI
PUBMED
ScienceOn
|
24 |
Westerbacka J, Cornér A, Tiikkainen M, Tamminen M, Vehkavaara S, Häkkinen AM, Fredriksson J, Yki-Järvinen H. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 2004; 47: 1360-1369
PUBMED
|
25 |
Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, Kato T, Okuda J, Ida K. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 2005; 143: 722-728
PUBMED
|
26 |
Lim S, Park KS, Lee HK, Cho SI. Changes in the characteristics of metabolic syndrome in Korea over the period 1998-2001 as determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 2005; 28: 1810-1812
DOI
PUBMED
ScienceOn
|
27 |
The American Society of Hypertension. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. American Society of Hypertension. Am J Hypertens 1992; 5: 207-209
PUBMED
|
28 |
Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395
DOI
PUBMED
ScienceOn
|
29 |
Suh SY, Choi SE, Ahn HY, Yang HM, Kim YI, Sung NJ. The association between normal alanine aminotransferase levels and the metabolic syndrome: 2005 Korean National Health and Nutrition Examination Survey. Metabolism; 2009
DOI
PUBMED
ScienceOn
|
30 |
NCEP. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
DOI
PUBMED
ScienceOn
|
31 |
Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144: 5159-5165
DOI
ScienceOn
|
32 |
Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002; 23: 201-229
DOI
PUBMED
ScienceOn
|
33 |
Hanley AJ, Wagenknecht LE, Festa A, D'Agostino RB Jr, Haffner SM. Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2007; 30: 1819-1827
DOI
ScienceOn
|